Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
special purpose acquisition company
Biotech
BridgeBio's cancer spinout backs SPAC as path to Nasdaq
The biotech—which spun out of BridgeBio Pharma in May 2024—has $100 million cash to hand, while Helix is bringing $196 million to the table.
James Waldron
Feb 28, 2025 9:25am
Medera plans SPAC merger to advance cardiac gene therapies
Sep 5, 2024 10:50am
Adagio Medical picks up the tempo with $128M SPAC deal
Feb 15, 2024 1:40pm
Abpro inks SPAC deal to fund bispecific R&D years after axed IPO
Sep 22, 2023 9:20am
Calidi goes public via SPAC to push allogeneic cancer therapies
Sep 13, 2023 9:35am
Ross' SPAC backtracks on merger with Alzheimer's-focused biotech
Aug 24, 2023 8:55am
